The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib as first-line treatment for endometrial cancer: Longitudinal changes in circulating tumor DNA.
 
Shannon Westin
Consulting or Advisory Role - AstraZeneca; Caris Life Sciences; Clovis Oncology; Curio Science; Daiichi Sankyo; Eisai; EQRX; Genentech; Gerson Lehrman Group; Gilead Sciences; GlaxoSmithKline; Immunocore; Immunogen; Incyte; Lilly; Loxo/Lilly; Medscape; Merck; Mereo BioPharma; Mersana; Mersana; NGM Biopharmaceuticals; Nuvectis Pharma; Nuvectis Pharma; OncLive; pharma&; Roche; Seagen; Targeted Oncology; Verastem; Vincerx Pharma; Zentalis; ZielBio
Research Funding - AstraZeneca (Inst); Avenge Bio (Inst); Bayer (Inst); Bio-Path Holdings, Inc (Inst); Clovis Oncology (Inst); Daiichi Sankyo Europe GmbH (Inst); GlaxoSmithKline (Inst); GOG Foundation (Inst); Jazz Pharmaceuticals (Inst); Loxo/Lilly (Inst); Mereo BioPharma (Inst); Novartis (Inst); Nuvectis Pharma (Inst); Pfizer (Inst); Roche/Genentech (Inst); Zentalis (Inst)
 
Kathleen Moore
Leadership - GOG Partners; NRG Oncology (Inst)
Honoraria - Astellas Medivation; Clinical Education Alliance; Haymarket Medical Education; IDEOlogy Health; Medscape; The Clearity Foundation
Consulting or Advisory Role - AADi; Abbvie; ADC Therapeutics; AstraZeneca; BioNTech SE; Blueprint Medicines (Inst); Bristol Myers Squibb Foundation; Caris Life Sciences; Clovis Oncology; Corcept Therapeutics; Daiichi Sankyo Europe GmbH; Duality Biologics (Inst); Eisai; Elucida Oncology; Exelixis; Genentech/Roche; GlaxoSmithKline/Tesaro (Inst); immunocore; Immunogen; Iovance Biotherapeutics; Janssen Oncology; Loxo/Lilly; Merck; Mersana (Inst); Novocure; ProfoundBio; Regeneron; Roche; Sanofi/Aventis; Schrodinger (Inst); seagen; T knife; Takeda Science Foundation; Tango Therapeutics; Third Arc; Tubulis GmbH; Verastem/Pharmacyclics; Xencor; zentalis; zymeworks
Research Funding - Amgen (Inst); artios (Inst); AstraZeneca (Inst); Daiichi Sankyo/Lilly (Inst); Immunocore (Inst); Immunogen (Inst); Merck (Inst); Regeneron (Inst); Verastem (Inst)
Other Relationship - GOG Partners (Inst)
 
Michael Guy
No Relationships to Disclose
 
Scott Jordan
Consulting or Advisory Role - Eisai
Speakers' Bureau - Seagen
Travel, Accommodations, Expenses - Intuitive Surgical
 
Michael McHale
No Relationships to Disclose
 
Eirwen Miller
No Relationships to Disclose
 
Sobia Ozair
No Relationships to Disclose
 
Kimberly Resnick
No Relationships to Disclose
 
Molnár Szabolcs
No Relationships to Disclose
 
Flora Zagouri
Honoraria - AstraZeneca; Daiichi Sankyo Europe GmbH; Genesis Pharma; Gilead Sciences; Lilly; Merck; MSD; Novartis; Pfizer Hellas; Roche
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo Europe GmbH; Genesis Pharma; Gilead Sciences; Lilly; Merck; MSD Oncology; Novartis; Pfizer Hellas; Roche
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; Genesis Pharma; Gilead Sciences; Lilly; Merck; MSD Oncology; Novartis; Pfizer Hellas; Roche
 
Pauline Wimberger
No Relationships to Disclose
 
Lubomir Bodnar
No Relationships to Disclose
 
Shoji Kamiura
No Relationships to Disclose
 
Wang Wuliang
No Relationships to Disclose
 
Conor Donnelly
Employment - AstraZeneca; Exploristics
 
Xiaochun Liu
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Ross Stewart
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Ying Wang
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Sonia Iyer
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Els Van Nieuwenhuysen
Consulting or Advisory Role - AstraZeneca (Inst); Merck Serono (Inst); Oncoinvent; Regeneron (Inst)
Speakers' Bureau - AstraZeneca (Inst); GlaxoSmithKline (Inst)
Research Funding - AstraZeneca (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Oncoinvent (Inst); Regeneron (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline (Inst); Regeneron (Inst)